Skip to main content
Back
Watch Compare

Kezar Life Sciences, Inc.

Data quality: 100%
KZR
Nasdaq Manufacturing Chemicals
$7.37
▲ $0.02 (0.27%)
Mkt Cap: 54.11 M
Price
$7.34
Mkt Cap
54.11 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -51.79 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-64.12%
Below sector avg (-53.41%)
ROIC-52.14%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.02
Below sector avg (0.31)
Current Ratio7.06
Interest CoverageN/A

Valuation

PE (TTM)
-0.97
Above sector avg (-1.48)
P/B Ratio0.65
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.0 -1.5
P/B 0.7 1.6
ROE % -64.1 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 0.0 0.3

ETFs Holding This Stock

BRUSX BRUSX
0.36% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -56.03 M
ROE -64.12% ROA -54.18%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51.79 M
ROIC -52.14% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.02 Current Ratio 7.06
Interest Coverage N/A Asset Turnover 0.00
Working Capital 81.13 M Tangible Book Value 82.98 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.97 Forward P/E N/A
P/B Ratio 0.65 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -95.71%
Market Cap 54.11 M Enterprise Value 16.55 M
Per Share
EPS (Diluted TTM) -7.66 Revenue / Share 0.00
FCF / Share -7.03 OCF / Share -7.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92.42%
SBC-Adj. FCF -62.31 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 7.00 M — —
Net Income -56.03 M -83.74 M -101.87 M -68.24 M -54.63 M
EPS (Diluted) -7.66 -11.49 -1.40 -1.01 —
Gross Profit — — — — —
Operating Income -59.11 M -90.61 M -111.42 M -71.16 M -54.66 M
EBITDA — — — — —
R&D Expenses 33.76 M 65.74 M 85.70 M 51.01 M 38.94 M
SG&A Expenses — — — — —
D&A 897,000.0 1.04 M 1.07 M 1.02 M 1.51 M
Interest Expense — 1.59 M 1.55 M 1.19 M 159,000.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 76.65 M 144.68 M 221.24 M 299.57 M 217.93 M
Total Liabilities 6.57 M 27.77 M 33.67 M 29.70 M 21.06 M
Shareholders' Equity 70.07 M 116.92 M 187.57 M 269.87 M 196.88 M
Total Debt 0.0 5.11 M 10.00 M 10.00 M 10.00 M
Cash & Equivalents 71.88 M 41.75 M 35.49 M 40.46 M 62.88 M
Current Assets 75.73 M 137.49 M 206.95 M 285.72 M 211.65 M
Current Liabilities 6.57 M 20.33 M 17.74 M 11.00 M 8.21 M